Funding Agency:

The Pittsburgh Foundation

Total Project Period:

07/01/08 - 06/30/10

Total Project Award:

$10,000

Principal Investigator:

Deric M. Park, MD

Co-Investigator:

Arlan Mintz, MD

Project Summary:

There is a great need to develop new rationally designed therapies for GBM. The proposed research using a combination of RA and VPA is grounded on the preliminary data that such a combination can independently promote growth inhibition and may act synergistically to induce differentiation of GCSC.